DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION

Pro Medicus Limited

OTCPK:PMCU.F Stock Report

Market Cap: US$12.6b

  • Company Overview
    • Valuation
    • Future Growth
    • Past Performance
    • Financial Health
    • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Pro Medicus Management

Management criteria checks 4/4

Pro Medicus' CEO is Sam Hupert, appointed in Jan 1983, has a tenure of 43.67 years. total yearly compensation is A$1.07M, comprised of 95.7% salary and 4.3% bonuses, including company stock and options. directly owns 23.16% of the company’s shares, worth $2.92B. The average tenure of the management team and the board of directors is 7.7 years and 10.3 years respectively.

Key information

Sam Hupert

Chief executive officer

AU$1.1m

Total compensation

CEO salary percentage95.67%
CEO tenure43.7yrs
CEO ownership23.2%
Management average tenure7.7yrs
Board average tenure10.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Sam Hupert's remuneration changed compared to Pro Medicus's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2026AU$1mAU$1m

AU$265m

Mar 31 2026n/an/a

AU$250m

Dec 31 2025n/an/a

AU$235m

Sep 30 2025n/an/a

AU$175m

Jun 30 2025AU$1mAU$1m

AU$115m

Mar 31 2025n/an/a

AU$107m

Dec 31 2024n/an/a

AU$98m

Sep 30 2024n/an/a

AU$91m

Jun 30 2024AU$965kAU$921k

AU$83m

Mar 31 2024n/an/a

AU$76m

Dec 31 2023n/an/a

AU$70m

Sep 30 2023n/an/a

AU$65m

Jun 30 2023AU$1mAU$723k

AU$61m

Mar 31 2023n/an/a

AU$56m

Dec 31 2022n/an/a

AU$51m

Sep 30 2022n/an/a

AU$48m

Jun 30 2022AU$510kAU$475k

AU$44m

Mar 31 2022n/an/a

AU$41m

Dec 31 2021n/an/a

AU$38m

Sep 30 2021n/an/a

AU$34m

Jun 30 2021AU$508kAU$475k

AU$31m

Mar 31 2021n/an/a

AU$28m

Dec 31 2020n/an/a

AU$25m

Sep 30 2020n/an/a

AU$24m

Jun 30 2020AU$508kAU$475k

AU$23m

Compensation vs Market: Sam's total compensation ($USD760.13K) is below average for companies of similar size in the US market ($USD14.74M).

Compensation vs Earnings: Sam's compensation has been consistent with company performance over the past year.


CEO

Sam Hupert

43.7yrs
Tenure
AU$1,066,771
Compensation

Dr. Sam Aaron Hupert, M.B.B.S., MD has been the Chief Executive Officer and Managing Director at Pro Medicus Limited (alternate name: PRO Medicus Ltd.) since October 2010. Dr. Hupert serves as Member of Ad...


Leadership Team

NamePositionTenureCompensationOwnership
Sam Hupert
Co-Founder43.7yrsAU$1.07m23.16%
$ 2.9b
Anthony Hall
Co-Founder43.7yrsAU$307.19k23.11%
$ 2.9b
Danny English
Chief Financial Officer & Company Secretary3.5yrsAU$151.90k0.0014%
$ 172.9k
Malte Westerhoff
GM of Europe & Global CTOno dataAU$3.21m0.083%
$ 10.5m
Garry Sherriff
Head of Investor Relationsless than a yearno datano data
Brad Levin
GM of North America & Global Head of Marketingno dataAU$401.25kno data
Sharni Redenbach
People & Culture Director4.2yrsno datano data
Sean Lambright
Global Head of Sales - Visage Imaging Inc11.2yrsAU$1.21m0%
$ 0
Teresa Gschwind
Global Head of Customer Service of Visage Imaging Inc.no datano datano data
Tim Kern
Chief Strategy Officerno datano datano data
7.7yrs
Average Tenure

Experienced Management: PMCU.F's management team is seasoned and experienced (7.7 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Sam Hupert
Co-Founder43.7yrsAU$1.07m23.16%
$ 2.9b
Anthony Hall
Co-Founder43.7yrsAU$307.19k23.11%
$ 2.9b
Alice Joans Williams
Independent Non-Executive Director5yrsAU$150.00k0.0021%
$ 263.8k
Leigh Farrell
Independent Non-Executive Director9yrsAU$150.00k0.0041%
$ 512.5k
Peter Kempen
Chairman18.5yrsAU$300.00k0.60%
$ 76.1m
Deena Shiff
Independent Non-Executive Director6.1yrsAU$150.00k0.0026%
$ 328.2k
Anthony Glenning
Independent Non-Executive Director10.3yrsAU$150.00k0.011%
$ 1.4m
10.3yrs
Average Tenure

Experienced Board: PMCU.F's board of directors are seasoned and experienced ( 10.3 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/21 17:04
End of Day Share Price 2026/09/17 00:00
Earnings2026/06/30
Annual Earnings2026/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Pro Medicus Limited is covered by 23 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Josh KannourakisBarrenjoey Markets Pty Limited
John HesterBell Potter
Madeleine WilliamsCanaccord Genuity

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide